Convergent Therapeutics Appoints Barbara Duncan to Board of Directors
CAMBRIDGE, Mass., Dec. 11, 2024 /PRNewswire/ -- Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical therapies for the treatment of prostate cancer and other